Multiple sclerosis: failure of treatment with verapamil in a pilot trial

S. Komoly, G. Jakab, A. Fazekas

Research output: Article

3 Citations (Scopus)

Abstract

Verapamil hydrocholoride, a lipophilic calcium channel blocking agent was used in the treatment of 11 patients with multiple sclerosis. The rationale of the therapy was to improve the conduction capacity of the damaged nerve fibres. The therapy did not prove effective in a pilot trial.

Original languageEnglish
Pages (from-to)59-60
Number of pages2
JournalJournal of Neurology
Volume233
Issue number1
DOIs
Publication statusPublished - febr. 1 1986

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Multiple sclerosis: failure of treatment with verapamil in a pilot trial'. Together they form a unique fingerprint.

  • Cite this